University of Minnesota Twin Cities researchers have developed a groundbreaking new diagnostic technique that will allow for faster and more accurate detection of neurodegenerative diseases that affect humans, such as Alzheimer’s and Parkinson’s, and similar diseases that affect animals, such as chronic wasting disease (CWD) and mad cow disease.
CREDIT: Sang-Hyun Oh Research Group, University of Minnesota
Researchers’ groundbreaking new diagnostic technique will allow for faster and more accurate disease detection
University of Minnesota Twin Cities researchers have developed a groundbreaking new diagnostic technique that will allow for faster and more accurate detection of neurodegenerative diseases. The method will likely open a door for earlier treatment and mitigation of various diseases that affect humans, such as Alzheimer’s and Parkinson’s, and similar diseases that affect animals, such as chronic wasting disease (CWD).
Their new study is published in Nano Letters, a premier journal in the field of nanotechnology published by the American Chemical Society.
“This paper mainly focuses on chronic wasting disease in deer, but ultimately our goal is to expand the technology for a broad spectrum of neurodegenerative diseases, Alzheimer’s and Parkinson’s being the two main targets,” said Sang-Hyun Oh, senior co-author of the paper and a Distinguished McKnight University Professor in the University of Minnesota Department of Electrical and Computer Engineering. “Our vision is to develop ultra-sensitive, powerful diagnostic techniques for a variety of neurodegenerative diseases so that we can detect biomarkers early on, perhaps allowing more time for the deployment of therapeutic agents that can slow down the disease progression. We want to help improve the lives of millions of people affected by neurodegenerative diseases.”
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, mad cow disease, and CWD (widely found in deer) share a common feature—the buildup of misfolded proteins in the central nervous system. Detecting these misfolded proteins is crucial for understanding and diagnosing these devastating disorders. However, existing diagnostic methods, like enzyme-linked immunosorbent assay and immunohistochemistry, can be expensive, time-consuming, and limiting in terms of antibody specificity.
The University of Minnesota researchers’ method, dubbed Nano-QuIC (Nanoparticle-enhanced Quaking-Induced Conversion), significantly improves the performance of advanced protein-misfolding detection methods, such as the NIH Rocky Mountain Laboratories’ Real-Time Quaking-Induced Conversion (RT-QuIC) assay.
The RT-QuIC method involves shaking a mixture of normal proteins with a small amount of misfolded protein, triggering a chain reaction that causes the proteins to multiply and allowing for the detection of these irregular proteins. Using tissue samples from deer, the University of Minnesota team demonstrated that adding 50-nanometer silica nanoparticles to RT-QuIC experiments dramatically reduces detection times from about 14 hours to only four hours and increases the sensitivity by a factor of 10.
A typical 14-hour detection cycle means that a lab technician can run only one test per normal working day. However, with a detection time of less than four hours, researchers can now run three or even four tests per day.
Having a quicker and highly accurate detection method is particularly important for understanding and controlling transmission of CWD, a disease that is spreading in deer across North America, Scandinavia, and South Korea. The researchers believe that Nano-QuIC could eventually prove useful for detecting protein-misfolding diseases in humans, specifically Parkinson’s, Creutzfeldt-Jakob Disease, Alzheimer’s, and ALS.
“Testing for these neurodegenerative diseases in both animals and humans has been a major challenge to our society,” said Peter Larsen, senior co-author of the paper and an assistant professor in the University of Minnesota Department of Veterinary and Biomedical Sciences. “What we’re seeing now is this really exciting time when new, next generation diagnostic tests are emerging for these diseases. The impact that our research has is that it’s greatly improving upon those next generation tests, it’s making them more sensitive, and it’s making them more accessible.”
The research was funded by the Minnesota Environment and Natural Resources Trust Fund as recommended by the Legislative-Citizen Commission on Minnesota Resources (LCCMR); the Minnesota Agricultural Experiment Station Rapid Agricultural Response Fund; and the Minnesota Agricultural, Research, Education, Extension and Technology Transfer (AGREETT) program.
“Minnesotans value science and support basic and applied research. As legislators, we have invested Environmental Trust Fund dollars to provide solutions for complex problems like chronic wasting disease,” said Representative Rick Hansen, chair of the Minnesota House Environment and Natural Resources Committee and co-chair of the LCCMR. “I am proud of the work of the LCCMR and the legislature in supporting this research and will continue to advocate for funding to research and prevent future problems affecting our wildlife and ourselves.”
Original Article: U of M researchers develop technique for rapid detection of neurodegenerative diseases like Parkinson’s and Chronic Wasting Disease
More from: University of Minnesota
The Latest Updates from Bing News
Go deeper with Bing News on:
Accurate disease detection
- 'Smart' contact lenses could someday enable wireless glaucoma detection
Most people with early-stage glaucoma don't know they have it, even though early treatment is key to reducing vision loss. While detecting a subtle increase in eye pressure helps doctors to diagnose ...
- Ensemble deep learning models enhance early diagnosis of Alzheimer's disease using neuroimaging data
By Dr. Priyom Bose, Ph.D. A recent Nature Mental Health study assessed the developments in ensemble deep learning (EDL) models used to characterize and estimate AD. Study: Ensemble deep learning for ...
- CIMA Sciences, In Partnership with Luxor Scientific Launches Revolutionary Liver Disease Test
CIMA recognizes the critical need for accurate and early detection of diseases and aims to revolutionize the diagnostic landscape and empower healthcare professionals with groundbreaking, accurate, ...
- Personalized screening early in pregnancy may improve preeclampsia detection
Study suggests more extensive screening method in the first trimester of pregnancy may improve detection of preeclampsia.
- Understanding IP Matters: How AI and IP Are Making a Difference in Early Cancer Detection
Huge datasets and limitless computing power are converging to upend the practice of healthcare, especially the speed and accuracy of detecting major diseases. Alan C. Nelson discusses this and more ...
Go deeper with Bing News on:
Detection of neurodegenerative diseases
- What brain health experts do every day to reduce their dementia risk
To prevent cognitive decline, there’s a whole host of habit changes you can make It’s the UK’s biggest killer, but right now there is nothing that can be done about dementia other than to treat its ...
- Advances in MRI may open window for treating neurodegenerative diseases
Technology behind MRI machines, among the most complex devices in modern medicine, is still developing after 70 years ...
- Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases
THN391 demonstrated effectiveness in protecting against vascular and neuronal degeneration - - Therini Bio plans to initiate a Phase 1/2a trial evaluating THN391 in DME in 2H24 - - The data was ...
- Alzheimer's News
Nanomaterial That Mimics Proteins Could Be Basis for New Neurodegenerative Disease Treatments Apr. 25, 2024 — A newly developed nanomaterial that mimics the behavior of proteins could be an ...
- Research suggests tear fluid testing as promising method for Huntington’s Disease monitoring
Huntington's disease (HD) is an autosomal-dominant, fully-penetrant, neurodegenerative disease that most commonly affects adults during middle age.